Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 24, 2017

DrugPatentWatch Database Preview

Calcipotriene - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for calcipotriene and what is the scope of calcipotriene patent protection?

is the generic ingredient in three branded drugs marketed by Fougera Pharms, Leo Pharm, Tolmar, Glenmark Generics, Leo Pharma As, Mayne Pharma, G And W Labs Inc, Glenmark Pharms, and Hi Tech Pharma, and is included in eleven NDAs. There are three patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Calcipotriene has twenty-five patent family members in twelve countries.

There are twelve drug master file entries for calcipotriene. Fourteen suppliers are listed for this compound.

Summary for Generic Name: calcipotriene

Drug Master File Entries: see list12
Suppliers / Packagers: see list14
Bulk Api Vendors: see list59
Clinical Trials: see list6
Patent Applications: see list6,049
Therapeutic Class:Dermatological Agents
Drug Prices:see low prices
DailyMed Link:calcipotriene at DailyMed

Pharmacology for Ingredient: calcipotriene

Ingredient-typeVitamin D
Drug ClassVitamin D Analog
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mayne Pharma
AEROSOL, FOAM;TOPICAL022563-001Oct 6, 2010RXYesYes8,629,128► SubscribeY ► Subscribe
Leo Pharma As
CREAM;TOPICAL020554-001Jul 22, 1996ABRXYesYes► Subscribe► Subscribe
Glenmark Pharms
CREAM;TOPICAL205772-001Jun 9, 2015ABRXNoNo► Subscribe► Subscribe
Mayne Pharma
AEROSOL, FOAM;TOPICAL022563-001Oct 6, 2010RXYesYes8,263,580► SubscribeY ► Subscribe
Hi Tech Pharma
SOLUTION;TOPICAL077579-001Nov 19, 2009ATRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Find generic sources and suppliers
  • Uncover prior art in abandoned patent applications and expired patents

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus